Clinical Trial Update: Unrelated Donor Transplant for Malignant and Non-Malignant Disorders [Phase 2]

View source ↗

Summary

Phase 2 trial of unrelated donor transplantation for malignant and non-malignant hematologic disorders; the study status is terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Marrow Failure Syndromes
• Histiocytosis
• Immunodeficiencies
• Leukemia
• Lymphoma

Snippet

Sponsor: Columbia University | Conditions: Leukemia, Lymphoma | Phase 2 | Status: TERMINATED